GlaxoSmithKline Suffers Further Asian Blow as India Revokes Patent on Cancer Drug Tykerb

GSK's patent for Tykerb revoked after company suffered from bribery allegations in China.



via IBTimes.com : Articles by Jerin Mathew http://www.ibtimes.co.uk/articles/496479/20130803/glaxosmithkline-india-tykerb-patent-china-bribery-scandal.htm August 03, 2013 at 12:09PM